CTOs on the Move

PeriGen, Inc.

www.perigen.com

 
PeriGen, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.perigen.com
  • 700 Alexander Park Ste 100
    Princeton, NJ USA '08540
  • Phone: 609.228.8346

Executives

Name Title Contact Details

Similar Companies

Pfizer

Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. We make medicines and vaccines that help people when they are sick and prevent them from getting sick in the first place, as well as some of the world`s best-known consumer healthcare brands. Every day, our colleagues work in developed and emerging markets to treat, cure and eradicate life-threatening conditions and challenge some of the most feared diseases of our time. Pfizer also collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

Gateway CHC

Gateway Community Health Center, Inc. is a community health center funded by the U.S. Department of Health and Human Services. The Center is a 501 (c) (3) private, non-profit corporation with a governing board of 15 directors whose responsibility is t...

PINNACLE CBO

PINNACLE CBO is a Lakewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Golden Years Medical Inc

Golden Years Medical Inc is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Histogenics

Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Histogenics` regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Histogenics` first investigational product candidate, NeoCart®, leverages its platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.